Artemisinin-independent inhibitory activity of Artemisia sp. infusions against different Plasmodium stages including relapse-causing hypnozoites
Open Access
- 2 December 2021
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 5 (3) , e202101237
Abstract
Artemisinin-based combination therapies (ACT) are the frontline treatments against malaria worldwide. Recently the use of traditional infusions from Artemisia annua (from which artemisinin is obtained) or Artemisia afra (lacking artemisinin) has been controversially advocated. Such unregulated plant-based remedies are strongly discouraged as they might constitute sub-optimal therapies and promote drug resistance. Here, we conducted the first comparative study of the anti-malarial effects of both plant infusions in vitro against the asexual erythrocytic stages of Plasmodium falciparum and the pre-erythrocytic (i.e., liver) stages of various Plasmodium species. Low concentrations of either infusion accounted for significant inhibitory activities across every parasite species and stage studied. We show that these antiplasmodial effects were essentially artemisinin-independent and were additionally monitored by observations of the parasite apicoplast and mitochondrion. In particular, the infusions significantly incapacitated sporozoites, and for Plasmodium vivax and P. cynomolgi, disrupted the hypnozoites. This provides the first indication that compounds other than 8-aminoquinolines could be effective antimalarials against relapsing parasites. These observations advocate for further screening to uncover urgently needed novel antimalarial lead compounds.Keywords
All Related Versions
Funding Information
- Labex ParaFrap-IRD PhD South program (ANR-11-LABX-0024)
- Fondation pour la Recherche Médicale (M19LRUN001)
- Agence Nationale de la Recherche (M18JRAR023)
- Fondation pour la Recherche Médicale (EQU202103012700)
- Agence Nationale de la Recherche (ANR-21-CE44-0010-01)
- Finovi program (Project Apicolipid)
- Laboratoire d’Excellence ParaFrap (ANR-11-LABX-0024)
- LIA-IRP CNRS Program (Project Apicolipid)
- CEFIPRA-MESRI (6003-1)
- Agence Nationale de la Recherche (ANR-17-CE13-0025-01)
- Programme d’Investissements d’Avenir (ANR-11-INBS-0008)
- Maison de l’Artémisia (N/A)
- Région Auvergne Rhone-Alpes, AuRA (IRICE GEMELI)
- Agence Nationale pour la Recherche (ANR-10-IAIHU)
- Institut Thématique Multi-Organismes ITMO I3M (N/A)
- Agence Nationale pour la Recherche (ANR-11-INSB-NeurATRIS)
This publication has 27 references indexed in Scilit:
- Anti-Plasmodial Polyvalent Interactions in Artemisia annua L. Aqueous Extract – Possible Synergistic and Resistance MechanismsPLOS ONE, 2013
- Atypical lipid composition in the purified relict plastid (apicoplast) of malaria parasitesProceedings of the National Academy of Sciences, 2013
- Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparumPLOS Biology, 2011
- Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug DiscoveryPLOS ONE, 2011
- A pre-emptive strike against malaria's stealthy hepatic formsNature Reviews Drug Discovery, 2009
- Type II fatty acid synthesis is essential only for malaria parasite late liver stage developmentCellular Microbiology, 2009
- Artemisia annua as a self-reliant treatment for malaria in developing countriesJournal of Ethnopharmacology, 2008
- The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial ParasitesCell Host & Microbe, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- High efficiency transfection of Plasmodium berghei facilitates novel selection proceduresMolecular and Biochemical Parasitology, 2006